Abstract
This chapter will discuss the role of folate nutrition in the unique environment of human skin. The folates are a family of structurally similar, water-soluble, B vitamins, which have been well documented as vital in promoting human health and preventing disease. Optimized folate nutrient levels support many biochemical processes important for the maintenance and function of healthy skin. This importance is underscored by potential links between folate deficiency and psoriasis, vitiligo, exfoliative dermatitis, glossitis, and skin cancers. Human skin is particularly prone to the development of carcinomas. It is established that skin cancer risk correlates with exposure to the complete carcinogen, ultraviolet radiation (UVR) from sunlight. Total avoidance of solar exposure is impractical.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- 5,10-Methylene-H4folate:
-
5,10-Methylenetetrahydrofolate
- 5-Formyl-H4folate:
-
5-Formyltetrahydrofolate
- 5-FU:
-
5-Fluorouracil
- 5-Methyl-H2folate:
-
5-Methyldihydrofolate
- 5-Methyl-H4folate:
-
5-Methyltetrahydrofolate
- AICAR:
-
Aminoimidazol-4-carboxamide ribonucleotide
- DHFR:
-
Dihydrofolate reductase
- dTMP:
-
Deoxythymidylate monophosphate
- dUMP:
-
Deoxyuridylate monophosphate
- FAICAR:
-
N-Formylaminoimidazol-4-carboxamide ribonucleotide
- FDA:
-
Food and Drug Administration
- FGAR:
-
N-Formylglycinamide ribonucleotide
- FOLR1:
-
Folate receptor
- FPGS:
-
Floyl-polyl-gamma(γ)-glutamate
- FRα:
-
Folate receptor alpha
- GAR:
-
Glycinamide ribonucleotide
- GGH:
-
Gamma(γ)-glutamyl hydrolase
- H2folate:
-
Dihydrofolate
- H4folate:
-
Tetrahydrofolate
- HCP:
-
Heme carrier protein
- Hcy:
-
Homocysteine
- hPCFT:
-
Human proton coupled folate transporters
- MS:
-
Methionine synthase
- MTHFR:
-
Methylenetetrahydrofolate reductase
- MTX:
-
Methotrexate
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate
- O2 :
-
Atmospheric oxygen
- O3 :
-
Ozone
- RCS:
-
Reactive carbonyl species
- RDA:
-
Recommended dietary allowances
- RFC:
-
Reduced folate carrier
- ROS:
-
Reactive oxygen species
- SAM:
-
S-Adenosylmethionine
- SHMT:
-
Hydroxymethyltransferase
- SPF:
-
Sun protection factor
- TS:
-
Thymidylate synthase
- UV:
-
Ultraviolet
- UV-A:
-
Ultraviolet light wavelength A (315–400 nm)
- UV-B:
-
Ultraviolet light wavelength B (280–315 nm)
- UV-C:
-
Ultraviolet light wavelength C (100–280 nm)
- UVR:
-
Ultraviolet radiation
References
Willis L. Treatment of pernicious anaemia of pregnancy and tropical anaemia with special reference to yeast extract as curative agent. Br Med J. 1931;1:1059–64.
Angier RB, et al. The structure and synthesis of the liver L. casei factor. Science. 1946;103(2683):667–9.
Mitchell HK, Snell EE, Williams RJ. The concentration of “folic acid”. J Am Chem Soc. 1941;63:2284.
Institute of Medicine. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Food and Nutrition Board NAoS, editor. Washington, DC: National Academy Press; 1998.
Raiten DJ, Fisher KD. Assessment of folate methodology used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). J Nutr. 1995;125(5):1371S–98.
Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL. Dietary intake of macronutrients, micronutrients and other dietary constituents: United States 1988–94. National Center for Health Statistics. Vital Health Stat. 2002;11(245):1–158.
Dietrich M, Brown CJ, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr. 2005;24(4):266–74.
Lewis CJ, et al. Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr. 1999;70(2):198–207.
Bailey LB, et al. Folacin and iron status and hematological findings in black and Spanish-American adolescents from urban low-income households. Am J Clin Nutr. 1982;35(5):1023–32.
Assantachai P, Lekhakula S. Epidemiological survey of vitamin deficiencies in older Thai adults: implications for national policy planning. Public Health Nutr. 2007;10(1):65–70.
Chandler CJ, Wang TT, Halsted CH. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. J Biol Chem. 1986;261(2):928–33.
Wang TT, Chandler CJ, Halsted CH. Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa. Isolation and characterization. J Biol Chem. 1986;261(29):13551–5.
Chandler CJ, et al. Functional specificity of jejunal brush-border pteroylpolyglutamate hydrolase in pig. Am J Physiol. 1991;260(6 Pt 1):G865–72.
Said HM, et al. Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency. Am J Physiol Cell Physiol. 2000;279(6):C1889–95.
Collins TD, et al. Effects of ethanol on tissue folate incorporation and recovery from folate deficiency in rats. Alcohol Clin Exp Res. 1992;16(4):757–63.
Nakai Y, et al. Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther. 2007;322(2):469–76.
Balamurugan K, Said HM. Role of reduced folate carrier in intestinal folate uptake. Am J Physiol Cell Physiol. 2006;291(1):C189–93.
Said HM, Redha R. A carrier-mediated transport for folate in basolateral membrane vesicles of rat small intestine. Biochem J. 1987;247(1):141–6.
Kalmbach RD, et al. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr. 2008;88(3):763–8.
Lucock MD, Hartley R, Smithells RW. A rapid and specific HPLC-electrochemical method for the determination of endogenous 5-methyltetrahydrofolic acid in plasma using solid phase sample preparation with internal standardization. Biomed Chromatogr. 1989;3(2):58–63.
Brzezinska A, Winska P, Balinska M. Cellular aspects of folate and antifolate membrane transport. Acta Biochim Pol. 2000;47(3):735–49.
Weitman SD, et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 1992;52(23):6708–11.
Henderson GB. Folate-binding proteins. Annu Rev Nutr. 1990;10:319–35.
Bosson G. Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell. Br J Biomed Sci. 2003;60(2):117–29.
Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm. 1989;45:263–335.
Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. 2000;71(1–2):121–38.
Zeng H, et al. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001;61(19):7225–32.
Matherly LH, Goldman DI. Membrane transport of folates. Vitam Horm. 2003;66:403–56.
Ifergan I, Jansen G, Assaraf YG. The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis. J Biol Chem. 2008;283(30):20687–95.
Kompis IM, Islam K, Then RL. DNA and RNA synthesis: antifolates. Chem Rev. 2005;105(2):593–620.
Green JM, Ballou DP, Matthews RG. Examination of the role of methylenetetrahydrofolate reductase in incorporation of methyltetrahydrofolate into cellular metabolism. FASEB J. 1988;2(1):42–7.
Stokstad EL, Koch J. Folic acid metabolism. Physiol Rev. 1967;47(1):83–116.
Matthews RG, Baugh CM. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroylpolyglutamate inhibitors. Biochemistry. 1980;19(10):2040–5.
Wagner C, Briggs WT, Cook RJ. Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun. 1985;127(3):746–52.
Milunsky A, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262(20):2847–52.
Honein MA, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285(23):2981–6.
De Wals P, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135–42.
Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008;28(1):3–13.
Mudd SH, et al. Homocystinuria: an enzymatic defect. Science. 1964;143:1443–5.
Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338(15):1042–50.
Lonn E, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354(15):1567–77.
Clarke R, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55(11):1449–55.
Godfrey PS, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336(8712):392–5.
Slattery ML, et al. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1999;8(6):513–8.
Zhang S, et al. A prospective study of folate intake and the risk of breast cancer. JAMA. 1999;281(17):1632–7.
Stolzenberg-Solomon RZ, et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol. 2001;153(7):680–7.
Fang JY, et al. Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. J Gastroenterol. 1997;32(2):171–5.
Butterworth Jr CE. Folate status, women’s health, pregnancy outcome, and cancer. J Am Coll Nutr. 1993;12(4):438–41.
Kamei T, et al. Experimental study of the therapeutic effects of folate, vitamin A, and vitamin B12 on squamous metaplasia of the bronchial epithelium. Cancer. 1993;71(8):2477–83.
Skibola CF, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96(22):12810–5.
Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2007;28(2):390–7.
Goldsmith LA. Physiology, biochemistry, and molecular biology of the skin, vol. 1. 2nd ed. New York: Oxford University Press; 1991.
Jonak C, Klosner G, Trautinger F. Significance of heat shock proteins in the skin upon UV exposure. Front Biosci. 2009;14:4758–68.
Antoniou C, et al. Photoaging: prevention and topical treatments. Am J Clin Dermatol. 2010;11(2):95–102.
Williams JD, Jacobson MK. Photobiological implications of folate depletion and repletion in cultured human keratinocytes. J Photochem Photobiol B. 2010;99(1):49–61.
Bjorkegren K, Svardsudd K. Reported symptoms and clinical findings in relation to serum cobalamin, folate, methylmalonic acid and total homocysteine among elderly Swedes: a population-based study. J Intern Med. 2003;254(4):343–52.
Meiss F, Marsch WC, Fischer M. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol. 2006;16(2):159–62.
Gisondi P, et al. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18(3):138–46.
Montes LF, et al. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis. 1992;50(1):39–42.
Fry L, et al. The mechanism of folate deficiency in psoriasis. Br J Dermatol. 1971;84(6):539–44.
Hild DH. Folate losses from the skin in exfoliative dermatitis. Arch Intern Med. 1969;123(1):51–7.
Vanizor Kural B, et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta. 2003;332(1–2):23–30.
Malerba M, et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol. 2006;155(6):1165–9.
AAD. Psoriasis triggers. Psoriasis Net; 2008.http://www.skincarephysicians.com/psoriasisnet/triggers.html.
Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond). 2006;30(8):1197–202.
Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46(10):1582–8.
Leuchtenberger R, et al. The Influence of “folic acid” on spontaneous breast cancers in mice. Science. 1945;101(2611):46.
Farber S, et al. The action of pteroylglutamic conjugates on man. Science. 1947;106(2764):619–21.
Farber S, Diamond LK. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med. 1948;238(23):787–93.
Ulrey CL, et al. The impact of metabolism on DNA methylation. Hum Mol Genet. 2005;14(Spec No 1):R139–47.
Duthie SJ, et al. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr Cancer. 2000;37(2):245–51.
Duthie SJ, et al. Impact of folate deficiency on DNA stability. J Nutr. 2002;132(8 Suppl):2444S–9.
Sanjoaquin MA, et al. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825–8.
Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51(3):267–92.
Jaszewski R, et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol. 2008;14(28):4492–8.
Logan RF, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology. 2008;134(1):29–38.
Cole BF, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351–9.
Kim YI. Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2220–5.
Weinstock MA. The struggle for primary prevention of skin cancer. Am J Prev Med. 2008;34(2):171–2.
NCI. Skin cancer facts and figures 2008.www.nci.nih.gov/cancertopics/types/skin. 2008.
Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol. 2003;157(7):571–82.
Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78(1):523–6.
Mandola MV, et al. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics. 2004;14(5):319–27.
Ulrich CM, et al. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev. 2000;9(12):1381–5.
Kang SY, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin. Mol Med Report. 2010;3(5):741–7.
Laing ME, et al. Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients. Transplantation. 2007;84(1):113–6.
Peters GJ, Kohne CH. Fluoropyrimidines as antifolate drugs. In: Jackson AL, editor. Antifolate drugs in cancer therapy. Totowa, NJ: Humana Press; 1999.
Hagner N, Joerger M. Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res. 2010;2:293–301.
Matz H. Phototherapy for psoriasis: what to choose and how to use: facts and controversies. Clin Dermatol. 2010;28(1):73–80.
Branda RF, Eaton JW. Skin color and nutrient photolysis: an evolutionary hypothesis. Science. 1978;201(4356):625–6.
Jablonski NG, Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci U S A. 2010;107 Suppl 2:8962–8.
Cohn BA. The vital role of the skin in human natural history. Int J Dermatol. 1998;37(11):821–4.
Chaplin G. Geographic distribution of environmental factors influencing human skin coloration. Am J Phys Anthropol. 2004;125(3):292–302.
Blum HF. Does the melanin pigment of human skin have adaptive value? An essay in human skin have adaptive value? An essay in human ecology and the evolution of race. Q Rev Biol. 1961;36:50–63.
Loomis WF. Skin-pigment regulation of vitamin-D biosynthesis in man. Science. 1967;157(788):501–6.
Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981;77(1):51–8.
Holick MF, MacLaughlin JA, Doppelt SH. Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science. 1981;211(4482):590–3.
Post PW, Daniels Jr F, Binford Jr RT. Cold injury and the evolution of “white” skin. Hum Biol. 1975;47(1):65–80.
Yuen AW, Jablonski NG. Vitamin D: in the evolution of human skin colour. Med Hypotheses. 2010;74(1):39–44.
MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20 Suppl 6:61–7.
Stratton SP, Dorr RT, Alberts DS. The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer. 2000;36(10):1292–7.
Lober BA, Lober CW, Accola J. Actinic keratosis is squamous cell carcinoma. J Am Acad Dermatol. 2000;43(5 Pt 1):881–2.
Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001;475(1–2):7–20.
Ullrich SE. Photoimmune suppression and photocarcinogenesis. Front Biosci. 2002;7:d684–703.
Wondrak GT, et al. Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem Pharmacol. 2002;63(3):361–73.
Wondrak GT, et al. Proteins of the extracellular matrix are sensitizers of photo-oxidative stress in human skin cells. J Invest Dermatol. 2003;121(3):578–86.
Wondrak GT, et al. Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins. J Invest Dermatol. 2002;119(2):489–98.
Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006;5(2):215–37.
Jeffes III EW, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol. 2000;1(3):167–79.
Guenthner ST, et al. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation. J Am Acad Dermatol. 1999;41(3 Pt 1):443–8.
Hurwitz RM, Monger LE. Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg. 1995;21(2):184.
de Gruijl FR. UV-induced immunosuppression in the balance. Photochem Photobiol. 2008;84(1):2–9.
Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol. 2001;45(4):528–36.
Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524–30.
Chen J, et al. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008;100(17):1215–22.
Marks R. An overview of skin cancers. Incidence and causation. Cancer. 1995;75(2 Suppl):607–12.
Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003;88(2):296–307.
Lucock M. Folic acid: beyond metabolism. J Evid Based Complementary Altern Med. 2011;16(2):102–13.
Off MK, et al. Ultraviolet photodegradation of folic acid. J Photochem Photobiol B. 2005;80(1):47–55.
Steindal AH, et al. Photodegradation of 5-methyltetrahydrofolate: biophysical aspects. Photochem Photobiol. 2006;82(6):1651–5.
Steindal AH, et al. 5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin. Photochem Photobiol Sci. 2008;7(7):814–8.
Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr. 2001;21:255–82.
McNulty H, et al. Folate catabolism is related to growth rate in weanling rats. J Nutr. 1995;125(1):99–103.
Thody AJ, et al. Pheomelanin as well as eumelanin is present in human epidermis. J Invest Dermatol. 1991;97(2):340–4.
Schallreuter KU, et al. Regulation of melanogenesis—controversies and new concepts. Exp Dermatol. 2008;17(5):395–404.
Schallreuter KU. Advances in melanocyte basic science research. Dermatol Clin. 2007;25(3):283–91. vii.
Shaheen MA, Fattah NS, El-Borhamy MI. Analysis of serum folate levels after narrow band UVB exposure. EDOJ. 2006;2(1):1–7.
Fukuwatari T, Fujita M, Shibata K. Effects of UVA irradiation on the concentration of folate in human blood. Biosci Biotechnol Biochem. 2009;73(2):322–7.
El-Saie LT, et al. Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis. Lasers Med Sci. 2011;26(4):481–5.
Gambichler T, et al. Serum folate levels after UVA exposure: a two-group parallel randomised controlled trial. BMC Dermatol. 2001;1:8.
Juzeniene A, et al. Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure. J Photochem Photobiol B. 2010;101(2):111–6.
Rose RF, et al. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis. J Am Acad Dermatol. 2009;61(2):259–62.
Cicarma E, et al. Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol. 2010;19(8):e67–72.
Dainichi T, et al. By the grace of peeling: the brace function of the stratum corneum in the protection from photo-induced keratinocyte carcinogenesis. Arch Dermatol Res. 2008;300 Suppl 1:S31–8.
Hirakawa K, et al. Sequence-specific DNA damage induced by ultraviolet A-irradiated folic acid via its photolysis product. Arch Biochem Biophys. 2003;410(2):261–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bermudez, Y., Cordova, K., Williams, J.D. (2013). Folate Nutrition in Skin Health and Skin Cancer Prevention. In: Watson, R., Zibadi, S. (eds) Bioactive Dietary Factors and Plant Extracts in Dermatology. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-167-7_22
Download citation
DOI: https://doi.org/10.1007/978-1-62703-167-7_22
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-166-0
Online ISBN: 978-1-62703-167-7
eBook Packages: MedicineMedicine (R0)